Evidence map›Paper›PMID 40931862›Full record

ArticleHaematologica2026

Immune intervention is dispensable for retinoic acid/ arsenic therapy of murine acute promyelocytic leukemia.

Cécile Esnault, Gael Fortin, Fang Qiu, Hassane Soilihi, Sylvie Souquère, Michiko Niwa-Kawakita, Kassandra Lanchais, Thassadite Dirami, Gérard Pierron, Hugues De Thé

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Cécile EsnaultUniversité Paris-Cité, INSERM U1342, CNRS EMR8000, IRSL, Hôpital Saint-Louis, Paris.
Gael FortinUniversité Paris-Cité, INSERM U1342, CNRS EMR8000, IRSL, Hôpital Saint-Louis, Paris.
Fang QiuUniversité Paris-Cité, INSERM U1342, CNRS EMR8000, IRSL, Hôpital Saint-Louis, Paris.
Hassane SoilihiUniversité Paris-Cité, INSERM U1342, CNRS EMR8000, IRSL, Hôpital Saint-Louis, Paris.
Sylvie SouquèreAMMICA, UMS-3655, Institut Gustave Roussy, Villejuif.
Michiko Niwa-KawakitaUniversité Paris-Cité, INSERM U1342, CNRS EMR8000, IRSL, Hôpital Saint-Louis, Paris.
Kassandra LanchaisUniversité Paris-Cité, INSERM U1342, CNRS EMR8000, IRSL, Hôpital Saint-Louis, Paris.
Thassadite DiramiUniversité Paris-Cité, INSERM U1342, CNRS EMR8000, IRSL, Hôpital Saint-Louis, Paris.
Gérard PierronCNRS, UMR-9196, Institut Gustave Roussy, Villejuif.
Hugues De ThéUniversité Paris-Cité, INSERM U1342, CNRS EMR8000, IRSL, Hôpital Saint-Louis, Paris, France; Collège de France, Chaire d'Oncologie Cellulaire et Moléculaire, PSL Research University, and INSERM U1050, CNRS UMR 7241, Paris, France; Service d'hématologie biologique, Hôpital Saint-Louis, AP/HP, Paris. hugues.dethe@inserm.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40931862
PMCPMC13231084

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.